Avapritinib Rollover Study

NCT06748001 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Mastocytosis, Systemic

Interventions

DRUG: Avapritinib

Sponsor

Blueprint Medicines Corporation